ADXN (ADXN) Stock Price & Analysis
ADXN (ADXN) rose 1.37% to USD 3.7 as of September 8, 2026 at 23:00 UTC, according to Nexqual real-time market data.
ADXN last closed at USD 3.7; the session ranged USD 3.53–3.76 on volume of 60,149 shares. Market capitalization is —, with a 52-week range of USD 3.4–12.05 (NCM). Source: Nexqual, September 8, 2026 at 23:00 UTC.
Key Statistics (as of September 8, 2026 at 23:00 UTC)
| Price | USD 3.7 |
|---|---|
| Change | ▲ 1.37% (up) |
| Previous Close | USD 3.7 |
| Open | USD 3.7 |
| Day Range | USD 3.53 – 3.76 |
| 52-Week Range | USD 3.4 – 12.05 |
| Volume | 60,149 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ADXN)
Nexqual's technical model rates ADXN "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 23:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.63 (neutral) |
| vs SMA50 | Below (USD 5.33) |
| MACD | -0.57 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFIB | Acutus Medical Inc. | USD 0 | ▲ 0% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.25 | ▲ 1.63% |
| NMAD | Nomad Power Solutions, Inc. | USD 3.86 | ▲ 5.33% |
| BCDA | BioCardia, Inc. | USD 1.11 | ▲ 1.83% |
| KZIA | Kazia Therapeutics Limited | USD 12.01 | ▼ 1.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 23:00 UTC. This page is informational and not investment advice.